Cite
Rational Design of Highly Potent and Selective Covalent MAP2K7 Inhibitors.
MLA
Kim, Dalton R., et al. “Rational Design of Highly Potent and Selective Covalent MAP2K7 Inhibitors.” ACS Medicinal Chemistry Letters, vol. 14, no. 5, May 2023, pp. 606–13. EBSCOhost, https://doi.org/10.1021/acsmedchemlett.3c00029.
APA
Kim, D. R., Orr, M. J., Kwong, A. J., Deibler, K. K., Munshi, H. H., Bridges, C. S., Chen, T. J., Zhang, X., Lacorazza, H. D., & Scheidt, K. A. (2023). Rational Design of Highly Potent and Selective Covalent MAP2K7 Inhibitors. ACS Medicinal Chemistry Letters, 14(5), 606–613. https://doi.org/10.1021/acsmedchemlett.3c00029
Chicago
Kim, Dalton R., Meghan J. Orr, Ada J. Kwong, Kristine K. Deibler, Hasan H. Munshi, Cory Seth Bridges, Taylor Jie Chen, Xiaoyu Zhang, H. Daniel Lacorazza, and Karl A. Scheidt. 2023. “Rational Design of Highly Potent and Selective Covalent MAP2K7 Inhibitors.” ACS Medicinal Chemistry Letters 14 (5): 606–13. doi:10.1021/acsmedchemlett.3c00029.